What is dannce.ai?
dannce.ai provides a sophisticated markerless motion capture platform designed to transform how researchers and clinicians quantify behavior. By utilizing advanced deep learning architectures, the company offers a non-invasive solution that detects neurological conditions with high precision. The platform is engineered for seamless integration into existing clinical workflows, providing actionable insights that bridge the gap between raw behavioral data and clinical decision-making. With a leadership team comprising experts in computational ethology and neuroscience, the company is effectively digitizing the motor exam, offering a scalable alternative to traditional, subjective assessment methods. Its market position is defined by its ability to serve both academic research environments and high-stakes clinical trial settings, making it a versatile tool in the modern biotech landscape.
How much funding has dannce.ai raised?
dannce.ai has raised a total of $2.6M across 1 funding round:
Other Financing Round
$2.6M
Other Financing Round (2024): $2.6M with participation from Glasswing Ventures, Duke Capital Partners, and LDV Capital
Key Investors in dannce.ai
Glasswing Ventures
Glasswing Ventures invests in visionary, early-stage founders who are leveraging AI and frontier technology to transform enterprise and security markets.
Duke Capital Partners
Duke Capital Partners is dedicated to empowering bold founders within the Duke community to build transformative companies by providing access to capital and mentorship.
LDV Capital
LDV Capital is an investment firm that focuses on collaborating with deep tech teams developing businesses powered by visual technology, computer vision, and artificial intelligence.
What's next for dannce.ai?
With this major enterprise-level funding, dannce.ai is poised to scale its operations and expand its footprint within the clinical diagnostics market. The strategic roadmap likely includes the expansion of its proprietary neural network models to encompass a broader range of neurological disorders, thereby increasing the utility of its automated motor exam. Furthermore, the company is expected to focus on strengthening its regulatory pathway, ensuring that its markerless motion capture technology meets the rigorous standards required for widespread clinical adoption. By fostering deeper partnerships with pharmaceutical companies and healthcare providers, dannce.ai aims to establish its platform as the gold standard for objective behavioral quantification, ultimately driving better patient outcomes through superior diagnostic accuracy and operational efficiency.
See full dannce.ai company page
